{
  "contract_id": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement_cleaned",
  "original_file": "ConformisInc_20191101_10-Q_EX-10.6_11861402_EX-10.6_Development Agreement_cleaned.txt",
  "chunk_size": 1000,
  "chunk_overlap": 200,
  "total_chunks": 56,
  "chunks": [
    "Execution Version Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. DEVELOPMENT AGREEMENT This Development Agreement (\"this Agreement\") is entered into and effective as of September 30, 2019 (\"Effective Date\") by and between Howmedica Osteonics Corp., a New Jersey corporation, also known as Stryker Orthopaedics (\"Stryker\"), and Conformis, Inc., a Delaware corporation having a principal place of business located at 600 Technology Park Drive, Billerica, MA 01821 (\"Conformis\")",
    ". Stryker and Conformis are collectively referred to herein as the \"Parties\" and individually as a \"Party.\" WHEREAS, the Parties are concurrently entering into an asset purchase agreement for Stryker's purchase of certain Conformis assets concerning Patient-Specific Instrumentation (\"Asset Purchase Agreement\"), and a License Agreement, a Distribution Agreement and a Quality Agreement, as defined in and attached to the Asset Purchase Agreement (collectively, such agreements are referred to herein as the \"Other Agreements\"). WHEREAS, Stryker and its Affiliates have developed and commercialized an Off-The-Shelf Knee Implant offered under the trademark Triathlon. WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants, including partial and total knee and hip arthroplasty",
    ". WHEREAS, Conformis currently offers Patient-Specific Instrumentation for use with its Patient-Specific Implants, including partial and total knee and hip arthroplasty. WHEREAS, Stryker desires that Conformis develop, in accordance with the R&D Program, certain Patient-Specific Instrumentation to be used with the current version of the Off-The-Shelf Knee Implant offered under the trademark Triathlon (such Patient-Specific Instrumentation as so developed, the \"KIB Product\"). THEREFORE, in consideration of the mutual representations, warranties and covenants herein and in the Other Agreements constituting good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows: ARTICLE I DEFINITIONS 1.1 Definitions",
    ". For purposes of this Agreement, the following terms shall have the following meanings, and to the extent not defined in this section or otherwise in this Agreement, a term shall have the meaning ascribed to it in any of the Other Agreements: Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "assignee, custodian, trustee, sequestrator (or other similar official) of such Party or of all or any substantial part of its property, or shall make an assignment for the benefit of creditors. \"Intellectual Property\" has the meaning set forth in the Asset Purchase Agreement. \"Invention\" means any idea, invention, discovery, know-how, data, work of authorship, information, improvement, technology, process, concept or material, whether or not patentable, copyrightable or protectable as a trade secret, and whether or not reduced to practice or memorialized in writing. \"Joint CI\" has the meaning set forth in the Asset Purchase Agreement. \"Joint IP\" has the meaning set forth in Article 5.1(c) of this Agreement. \"Joint IP Rights\" has the meaning set forth in Article 5.8 of this Agreement. \"KIB Product\" has the meaning set forth in the recitals",
    ". \"Joint IP Rights\" has the meaning set forth in Article 5.8 of this Agreement. \"KIB Product\" has the meaning set forth in the recitals. \"KIB Product IP\" means any Invention first arising in the performance of the R&D Program, whether or not embodied in the KIB Product, and all Intellectual Property rights underlying such Invention (but expressly excluding all Transferred IP, Conformis Background IP, Stryker Background IP, Improved Conformis Background IP and Improved Stryker Background IP, and, for the avoidance of doubt, excluding all Intellectual Property rights subsisting prior to the Closing Date). \"License Agreement\" has the meaning set forth in the Asset Purchase Agreement. \"Off-The-Shelf Implant\" has the meaning set forth in the Asset Purchase Agreement. 5 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "\"Off-The-Shelf Knee Implant\" has the meaning set forth in the Asset Purchase Agreement. \"Other Agreements\" has the meaning set forth in the recitals. \"Patents\" has the meaning set forth in the Asset Purchase Agreement. \"Patient-Specific Implants\" has the meaning set forth in the Asset Purchase Agreement. \"Patient-Specific Instrumentation\" has the meaning set forth in the Asset Purchase Agreement. \"Person\" has the meaning set forth in the Asset Purchase Agreement. \"Prior CDA\" has the meaning set forth in the Asset Purchase Agreement. \"Purchased Assets\" has the meaning set forth in the Asset Purchase Agreement. \"Receiving Party\" has the meaning set forth in the Asset Purchase Agreement. \"Redelivery Period\" has the meaning set forth in Article 3.4 of this Agreement. \"R&D Program\" means work performed in the development of the KIB Product under this Agreement pursuant to the R&D Work Plan. \"R&D Work Plan\" means the research and development plan set forth in Exhibit 1",
    ". \"R&D Work Plan\" means the research and development plan set forth in Exhibit 1. \"Relevant Indemnified Parties\" means (a) if Stryker is the indemnified Party, the Stryker Indemnified Parties and (b) if Conformis is the indemnified Party, the Conformis Indemnified Parties. 6 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "\"Representatives\" has the meaning set forth in the Asset Purchase Agreement. \"Stryker Background IP\" means any Invention, and all Intellectual Property rights underlying such Invention, that is, as of the Effective Date owned or licensable by Stryker without causing a breach of, or incurring any obligation to, a third party, in each case to the extent each such Invention is (a) necessary or reasonably useful to design, develop, manufacture, sell and otherwise exploit the KIB Product and (b) provided to Conformis by or on behalf of Stryker in connection with Conformis' activities under this Agreement, and, for the avoidance of doubt, excluding the Transferred IP, Conformis Background IP, Improved Conformis Background IP and Improved Stryker Background IP. \"Stryker Indemnified Parties\" has the meaning set forth in Article 7.3(a) of this Agreement. \"Stryker-Prosecuted Joint IP Rights\" has the meaning set forth in Article 5.8 of this Agreement",
    ". \"Stryker Indemnified Parties\" has the meaning set forth in Article 7.3(a) of this Agreement. \"Stryker-Prosecuted Joint IP Rights\" has the meaning set forth in Article 5.8 of this Agreement. \"Termination Notice\" means a written notice delivered by one Party to the other Party of its election to terminate this Agreement pursuant to Article VIII. \"Third Party\" has the meaning set forth in the Asset Purchase Agreement. \"Trademarks\" has the meaning set forth in the Asset Purchase Agreement. \"Transferred IP\" has the meaning set forth in the Asset Purchase Agreement. \"Triathlon\" has the meaning set forth in the Asset Purchase Agreement. \"Wire Instructions\" has the meaning set forth in the Asset Purchase Agreement. 7 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "entitled to repeat its acceptance analysis and testing process for the purposes of determining Acceptance as set forth in the R&D Work Plan until such Deliverable operates in accordance with or otherwise conforms to the applicable Acceptance Criteria; provided, however, that if Stryker properly rejects a particular Deliverable three (3) or more times in accordance with this Article III, or if Conformis fails to deliver a version or corrected version, as the case may be, of the Deliverable within any respective [**] period, Stryker may, terminate this Agreement in accordance with Section 8.2(c) (in the event of such three (3) rejections, Stryker \"Finally Rejects\" the Deliverable)",
    ". Such termination, together with the provisions of Section 5.2 of the License Agreement, constitutes as Stryker's sole remedy and Conformis' exclusive liability in the event of any such rejection or failure by Conformis to deliver materially conforming Deliverables hereunder so long as such rejection or failure does not arise from Conformis' fraud, willful misconduct, gross negligence or bad faith. Stryker shall be deemed to have accepted a Deliverable timely furnished to it unless (a) the Deliverable fails to operate in accordance with and otherwise conform the applicable Acceptance Criteria, and (b) Stryker provides Conformis a written Failure Notice within the Acceptance Notification Period in accordance with this Section 3.4 (any acceptance or deemed acceptance, described in this Section 3.4, \"Acceptance\" or \"Accept\"). Acceptance of a Deliverable shall not constitute a waiver of any rights Stryker may have based on Conformis' warranties set forth in this Agreement",
    ". Acceptance of a Deliverable shall not constitute a waiver of any rights Stryker may have based on Conformis' warranties set forth in this Agreement. 3.5 Payment for Milestones. Stryker shall pay to Conformis the following milestone payments for the development work to be conducted hereunder if and when the following milestones are met, as follows: (a) Milestone #1 - Within thirty (30) days following the date on which Stryker receives the first prototype of the Patient- Specific Instrumentation delivered to it by Conformis in accordance with the R&D Work Plan, Stryker shall pay to Conformis a total of two million U.S. dollars ($2,000,000); and 10 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "(b) Milestone #2 - Within thirty (30) days following the date on which there is a design freeze of the Patient-Specific Instrumentation for the KIB Product in accordance with the R&D Work Plan, Stryker shall pay to Conformis a total of three million U.S dollars ($3,000,000). 3.6 Payment. Stryker shall make all payments to Conformis required herein by wire transfer in accordance with the Wire Instructions. Such payments are non-refundable and non-creditable except as set forth in the Other Agreements. ARTICLE IV RESTRICTIVE COVENANT 4.1 Exclusivity",
    ". Such payments are non-refundable and non-creditable except as set forth in the Other Agreements. ARTICLE IV RESTRICTIVE COVENANT 4.1 Exclusivity. Except as specifically provided in the Distribution Agreement, Conformis shall be prohibited from developing or assisting another in developing, or causing another to develop, Patient-Specific Instrumentation for Off-The-Shelf Knee Implants for any Third Party in the field of orthopedics until January 1, 2032 (or earlier, to the extent set forth in Section 2.3.3.4 or Section 2.3.5 of the Distribution Agreement), with the exception that Conformis (including any entity involved in a Change of Control of Conformis, any such entity an \"Acquirer\"), may develop Patient-Specific Instrumentation for any Off-The- Shelf Implants of Conformis, an Acquirer or any of their Affiliates",
    ". For purposes of clarity, the foregoing does not prevent Conformis from granting any license, release, covenant not to sue or other immunity to any third party under any Patents, including any such immunity that would authorize manufacture, use or sale of Patient-Specific Instrumentation for Off-The-Shelf Knee Implants outside the Buyer Field. ARTICLE V INTELLECTUAL PROPERTY 5.1 Inventions. (a) Inventorship of all Inventions developed by either Party, or both Parties, in the performance of the R&D Program, shall be determined in accordance with the inventorship laws of the United States, even to the extent such Invention is not pursued in patent applications. (b) All right, title and interest in and to the Improved Stryker Background IP will vest solely in Stryker. Conformis agrees to assign and hereby assigns to Stryker all right, title and interest in and to all Improved Stryker Background IP in which ownership in same has vested in 11 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "Conformis by operation of law or by assignment by its employees or consultants; and to facilitate such assignment to Stryker, Conformis agrees (i) to regularly ensure that its employees and consultants timely make any appropriate assignments to it of that which constitutes Improved Stryker Background IP, and (ii) at Stryker's reasonable request, to execute and have its employees and consultants execute, as necessary, all assignments and any other documentation necessary to perfect title in Stryker of such Improved Stryker Background IP. (c) All right, title and interest in and to the Improved Conformis Background IP and KIB Product IP (\"Joint IP\") shall be owned jointly by the Parties",
    ". (c) All right, title and interest in and to the Improved Conformis Background IP and KIB Product IP (\"Joint IP\") shall be owned jointly by the Parties. Subject to the limitations set forth in this Agreement, the Joint IP may be used freely by either Party or its Affiliates and licensed to Third Parties by Conformis and its Affiliates, on the one hand, outside of the Buyer Field or by Stryker and its Affiliates, on the other hand, within the Buyer Field, in each case, without the consent of, or duty to account to or notify, the other Party, but, except with respect to external licenses of the Improved Conformis Background IP by Conformis or its Affiliates to Third Parties, any external Third Party license shall be governed in accordance with the last sentence of Section 4.3(c) of the APA",
    ". Each Party to whom ownership is to vest in Joint IP by operation of law or by assignment by its employees or Agents agrees to assign and hereby assigns to the other Party an undivided one-half right, title and interest in and to all Joint IP; and to facilitate such assignment, the Party possessing such ownership agrees (i) to regularly ensure that its employees and consultants timely make any appropriate assignments to it; and (ii) at the other Party's reasonable request, to execute and have its employees and consultants execute, as necessary, all assignments and any other documentation to perfect the undivided one-half right, title and interest in and to the other Party of such Joint IP",
    ". (d) Notwithstanding anything to the contrary, the foregoing does not constitute either (1) the grant by Conformis to Stryker of any license or immunity of any kind with respect to the Conformis Background IP or Conformis Foreground IP, regardless of the extent to which the Joint IP constitutes improvements to the Conformis Background IP or Conformis Foreground IP, (2) the grant by Stryker to Conformis of any license or immunity of any kind with respect to the Stryker Background IP, or (3) the grant by either Party of any license or immunity of any kind under any Intellectual Property rights owned by such Party, regardless of whether the exploitation of the Joint IP would infringe such Intellectual Property rights. Neither Party shall assign a partial interest in 12 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "(a) Conformis shall ensure that all its employees, consultants, Agents or other Third Parties who perform any portion of Conformis' R&D Program obligations under this Agreement have entered into written agreements with Conformis whereby such employee, consultant, Agent or other Third Party assigns to Conformis all ownership rights in any Inventions made or developed by such employee, consultant, Agent or Third Party in the course of such R&D Program work under this Agreement. (b) Stryker shall ensure that all its Affiliates and its or their employees, consultants, Agents or other Third Parties who perform any portion of Stryker's R&D Program obligations under this Agreement have entered into written agreements with Stryker whereby such employee, consultant, Agent or Third Party assigns to Stryker all ownership rights in any Inventions made or developed by such employee, consultant, Agent or Third Party in the course of such R&D Program work under this Agreement. 5.6 Tangible Property",
    ". 5.6 Tangible Property. (a) All tooling, patterns, dies, gauges, jobs, fixtures, and all specifications, drawings, samples, designs, software, firmware, programs, formulae, and other tangible items (\"Equipment\") furnished by Stryker to Conformis in connection with this Agreement: (i) shall only be used in the performance of the R&D Program; (ii) shall remain the property of Stryker; and (iii) shall be disposed of or returned in good repair, normal wear and tear excepted, by Conformis to Stryker at Stryker's direction and expense upon Stryker's request. Conformis assumes risk of loss and damage to said items while in its possession or under its control, subject to normal wear and tear. Conformis shall notify Stryker promptly whenever any items of Stryker's tangible property are in need of repair or replacement. Stryker shall endeavor to mark its property as property of Stryker for 14 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "use only under this Agreement. Conformis waives any right it may have in law or equity to withhold Stryker's property. (b) All Equipment furnished by Conformis to Stryker in connection with this Agreement: (i) shall only be used in the performance of the R&D Program; (ii) shall remain the property of Conformis; and (iii) shall be disposed of or returned in good repair, normal wear and tear excepted, by Stryker to Conformis at Conformis' direction and expense upon Conformis' request. Stryker assumes risk of loss and damage to said items while in its possession or under its control, subject to normal wear and tear. Stryker shall notify Conformis promptly whenever any items of Conformis' tangible property are in need of repair or replacement. Conformis shall endeavor to mark its property as property of Conformis for use only under this Agreement. Stryker waives any right it may have in law or equity to withhold Conformis' property. 5.7 Trademarks",
    ". Stryker waives any right it may have in law or equity to withhold Conformis' property. 5.7 Trademarks. Nothing in this Agreement shall confer to any Party any rights, whether by way of ownership, license or right to use, in any of the Trademarks of any other Party. Conformis shall not use the Trademarks of Stryker without Stryker's prior written consent and Stryker shall not use the Trademarks of Conformis without Conformis' prior written consent. 5.8 Prosecution of Patent Rights. Stryker shall be solely responsible, in its sole discretion, for preparing, filing, prosecuting and maintaining Patents arising from all Improved Stryker Background IP. Stryker shall be solely responsible for costs and expenses of preparing, filing, prosecuting and maintaining any such Patents. Stryker shall have the first right to prepare, file, prosecute and maintain Patents or copyrights arising from any Joint IP that is not Improved Conformis Background IP (\"Stryker- Prosecuted Joint IP Rights\")",
    ". Conformis shall have the first right to prepare, file, prosecute and maintain Patents or copyrights arising from any Improved Conformis Background IP (\"Conformis-Prosecuted Joint IP Rights\", and together with the Stryker- Prosecuted Joint IP Rights, \"Joint IP Rights\"). With respect to Joint IP Rights, the non-prosecuting Party will have the right, but not the obligation, to review and comment, and have the comments reasonably considered by the prosecuting Party, with regard to the filing, prosecution, 15 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "5.10 Publicity. Neither Party shall issue any press release or otherwise publicize this Agreement or the development work to be conducted hereunder, except in accordance with Section 4.2 of the APA. ARTICLE VI REPRESENTATIONS AND WARRANTIES 6.1 Representations, Warranties and Covenants. Each Party hereby represents and warrants to, and covenants with, each other Party that: (a) Due Organization. Good Standing and Power. It is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and has the power and authority to own, lease and operate its assets and to conduct the business now being conducted by it. It has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder. (b) Authorization and Validity of Agreement",
    ". It has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder. (b) Authorization and Validity of Agreement. The execution, delivery and performance by it of this Agreement and the consummation by it of the transactions contemplated hereby have been duly authorized and approved by all necessary corporate or equivalent action on its part. This Agreement has been duly executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other Applicable Laws relating to or affecting creditors' rights generally and by general equity principles. (c) Absence of Conflicts",
    ". (c) Absence of Conflicts. The execution, delivery and performance by it of this Agreement and the consummation by it of the transactions contemplated hereby do not and will not: (i) violate any Applicable Laws, regulations, orders, writs, injunctions or decrees of any governmental, judicial, legislative, executive, administrative or regulatory 17 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "their respective successors, heirs and assigns (collectively the \"Stryker Indemnified Parties\") against any and all claims, suits, actions, and demands, wherever brought and however denominated, brought by a Third Party (all of the foregoing being referred to herein as \"Claims\") against the Stryker Indemnified Party including all damages, collateral damages and settlements arising therefrom and reasonable outside attorneys' fees and litigation expenses related thereto, to the extent arising from or related to (i) any breach of Conformis' representations, warranties or obligations under this Agreement, (ii) any alleged violation of any Applicable Laws by Conformis, (iii) the negligence (excluding any product liability Claim), gross negligence or intentionally wrongful acts or omissions of Conformis, its employees, consultants, Agents and Affiliates in their performance hereunder, and (iv) any portion of a Claim alleging personal injury on account of product liability attributable to a",
    "Conformis, its employees, consultants, Agents and Affiliates in their performance hereunder, and (iv) any portion of a Claim alleging personal injury on account of product liability attributable to a Deliverable (including a Deliverable within a Product or a Stryker Product)",
    ". Conformis shall have no obligation or liability with respect to any Claim under Section 7.3(a)(iii) or Section 7.3(a)(iv) to the extent directly arising out of or relating to: (1) any use of the Products in any manner not in accordance with applicable documentation (e.g., instructions for use, package inserts, labels, surgical guides and other materials provided by or approved by Conformis) that is not a result of Conformis' conduct; (2) damage to the Products occurring after shipment that is not a result of Conformis' conduct; or (3) any modifications to the Products that are not contemplated by the instructions for use thereto by any Person other than Supplier and that is not a result of Conformis' conduct. Notwithstanding anything to the contrary, Stryker's sole remedy and Conformis' exclusive liability for breach of Section 3.2 with respect to a Product or a Stryker Product shall be as set forth in Section 10.1(i) of the Distribution Agreement. (b) Indemnification by Stryker",
    ". (b) Indemnification by Stryker. Stryker shall indemnify and hold harmless Conformis, its directors, officers, employees, Agents and 20 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "Affiliates and their respective successors, heirs and assigns (collectively the \"Conformis Indemnified Parties\") against any and all Claims against the Conformis Indemnified Parties to the extent arising from or related to (i) any breach of Stryker's representations or warranties under this Agreement, (ii) any alleged violation of any Applicable Laws by Stryker, and (iii) the grossly negligent or intentionally wrongful acts or omissions of Stryker, its employees, consultants, Agents and Affiliates in their performance hereunder. (c) Joint Liability",
    ". (c) Joint Liability. To the extent that Stryker, on the one hand, and Conformis, on the other hand, each has indemnification obligations to the other in connection with a single Claim, they will contribute to the aggregate damages, liabilities, costs and expenses arising from such Claim in a proportion reflecting the relative and comparative responsibilities and determined liability of the Parties for such damages, liabilities, costs and expenses, as well as any other relevant equitable considerations. The amount paid or payable by a Party for purposes: of apportioning the aggregate damages, liabilities, costs and expenses shall be deemed to include all reasonable legal fees and expenses incurred by such Party in connection with investigating, preparing for or defending against such Claim. (d) Indemnification Procedures. Claims for indemnification under this Agreement shall be governed by the indemnification procedures set forth in Section 5.5 of the Asset Purchase Agreement",
    ". (d) Indemnification Procedures. Claims for indemnification under this Agreement shall be governed by the indemnification procedures set forth in Section 5.5 of the Asset Purchase Agreement. (e) Settlement. If the indemnifying Party assumes the defense of a Claim, no compromise or settlement of such claims may be effected by the indemnifying Party without the indemnified Party consent unless: (a) there is no finding or admission of any violation of Applicable Requirements or any violation of the rights of any Person by the indemnified Party and no effect on any other claims that may be made against the indemnified Party, (b) the sole relief provided is 21 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "monetary damages that are paid in full by the indemnifying Party and (c) such settlement includes as an unconditional release of liability by such Third Party claimant in respect of all Indemnified Persons. ARTICLE VIII TERM AND TERMINATION 8.1 Term. The term of this Agreement shall begin as of the Effective Date and continue until Acceptance of all Deliverables for Milestones #1 and #2 pursuant to Section 3.4 and completion of Milestone #3, unless earlier terminated under Section 8.2, as provided for under the Other Agreements, or as mutually agreed by the Parties. 8.2 Termination. (a) Dissolution or Insolvency Event",
    ". Either Party may terminate this Agreement effective immediately upon delivery of a Termination Notice if the other Party is (A) dissolved or is seeking to dissolve itself under applicable corporate law other than as part of a corporate restructuring under which its assets were first transferred to an assignee under this Agreement in accordance with Section 10.2; or (B) (i) becomes subject to an Insolvency Event, provided that, no termination right shall exist in respect of an Insolvency Event that is a chapter 11 case under the Bankruptcy Code if the Party subject to such chapter 11 case (x) continues to perform all of its material obligations under this Agreement, (y) does not seek to reject this Agreement or take any action in such chapter 11 case to disavow or undermine the rights of the other Party under this Agreement, and (z) assumes this Agreement on or before any deadline in such chapter 11 case for such assumption; notwithstanding the foregoing, nothing herein shall limit or",
    "other Party under this Agreement, and (z) assumes this Agreement on or before any deadline in such chapter 11 case for such assumption; notwithstanding the foregoing, nothing herein shall limit or prevent the Party not subject to an Insolvency Event from objecting to assumption or assumption and assignment of this Agreement or requiring cure payments or adequate assurance 22 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "of future performance as a condition of assumption or assumption and assignment. (b) Default. If any Party believes the other is in material breach of any of its material obligations under this Agreement in a manner other than as set forth in Article III to which this Section 8.2(b) does not apply, it may give notice of such material breach to the allegedly breaching Party, which Party shall have [**] (or such longer period of time as may be reasonably commensurate with the effort reasonably required to remedy such default) in which to remedy such default. If such alleged material breach is not remedied in the time period set forth above, the Party alleging material breach shall refer the matter to the chief executive officers of each Party, who shall meet and confer within [**] after notice from the non-breaching Party of its desire for such a meeting",
    ". If the Parties are unable to resolve any dispute in such meeting and no Action has been brought in accordance with Section 10.8 with respect to such dispute, the non-breaching Party may terminate this Agreement immediately upon delivery to the defaulting Party of a Termination Notice. The non-defaulting Party's right to terminate this Agreement in accordance with this Section 8.2(b) shall not be construed as an exclusive remedy. (c) If Stryker Finally Rejects any Deliverable for Milestone #1 or #2 in accordance with Article III, Stryker may terminate this Agreement, which termination shall be effective immediately upon delivery of a Termination Notice to Conformis. 8.3 Surviving Rights/Obligations",
    ". 8.3 Surviving Rights/Obligations. (a) The provisions of Articles V, VI, VII and IX and Sections 8.3, 8.4, 10.1, 10.2, 10.5 - 10.13 and 10.15, together with any provisions required for the interpretation or enforcement of any of the foregoing, shall survive the termination or expiration of this Agreement, provided, however that Section 7.3(a)(iv) shall survive the termination or expiration of this Agreement for only [**] thereafter. The termination of this Agreement shall not relieve any Party from obligations that are expressly indicated to survive termination of the Agreement. 23 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "ARTICLE IX RECORD-KEEPING AND AUDITS 9.1 Records Retention. Each of the Parties shall record in written or electronic form all material information with respect to the performance of its obligations relating to the R&D Program in accordance with standard industry practices. ARTICLE X MISCELLANEOUS 10.1 Agency. Neither this Agreement nor any of the Other Agreements creates any partnership, agency or other relationship among the Parties for any purpose, including for all tax purposes. No Party is granted any right or authority to assume or to create any obligation or responsibility on behalf or in the name of the other Party or to bind the other Party in any manner whatsoever. 10.2 Assignment and Change of Control",
    ". Except as otherwise provided herein, a Party shall not have the right to assign any of its rights or obligations under this Agreement (whether through a merger, sale of stock, or otherwise) without the prior written consent of the other Party; except that, either Party shall be permitted, without any need for the other Party's consent, to assign this Agreement (a) in whole or in part to an Affiliate (provided, however, that once such Person is no longer an Affiliate of the assigning Party, such former Affiliate shall assign this Agreement back to the assigning Party), provided that the assigning Party provides the other Party notice of any such assignment provided further that failure to provide such notice of such assignment shall not render such assignment void; or (b) to a Third Party in connection with sale or transfer of all or substantially all of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger,",
    "in connection with sale or transfer of all or substantially all of the assigning Party's business or assets relating to the subject matter of this Agreement, whether by Change of Control, merger, sale of assets or otherwise; provided, however, that, with respect to clause (b), (i) any assignment of this Agreement shall be void and have no effect unless and until the assignee assumes the 25 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "obligations of the assigning Party in a written instrument, a copy of which is provided to the other Party; and (ii) any assignment of this Agreement must be accompanied by a simultaneous assignment of the Other Agreements to the same assignee, and the assigning Party's interest in the Purchased Assets to the same assignee unless otherwise agreed by Conformis in advance, which agreement shall not be unreasonably withheld. Any assignment in whole or in part shall not relieve the assigning Party of its obligations hereunder. If and to the extent that a Party assigns any of its rights and/or obligations hereunder in accordance with this Section 10.2, then this Agreement shall be binding upon the assignee to the same extent as if it were a Party hereto. Any assignment not in accordance with this Section 10.2 shall be void. 10.3 Further Actions",
    ". Any assignment not in accordance with this Section 10.2 shall be void. 10.3 Further Actions. Each Party agrees, subsequent to the execution and delivery of this Agreement and without any additional consideration, to execute, acknowledge and deliver such further documents and instruments, and to do all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement. 10.4 Force Majeure. (a) In the event that either Party is unable to perform any of its obligations under this Agreement, or to enjoy any of its benefits because of fire, natural disaster, action or decrees of Governmental Entities or any other event not within such Party's reasonable control (a \"Force Majeure Event\"), the Party who has been so affected shall give written notice to the other Party as soon as practicable and shall do everything reasonably possible to resume performance",
    ". Upon receipt of such notice, all obligations under the Agreement shall be immediately suspended. If the period of nonperformance exceeds [**] from the receipt of notice of the Force Majeure Event, the Party whose ability to perform has not been so affected may, by giving written notice, terminate the Agreement. Any acceptance or warranty period affected by a Force Majeure Event shall likewise be extended for a period equal to the duration of such Force Majeure Event. As applied to this Section 10.4 26 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "and to determine whether an event is reasonably beyond control of a Party, materials shortages, strikes, slowdowns, other labor related delays or events resulting from a Party's, its Affiliates or their respective agents' negligence, gross negligence, fraud or intentional misconduct are not Force Majeure Events. (b) Notwithstanding the provisions set forth in Section 10.4(a), above, a Force Majeure Event shall not include any governmental action of an enforcement nature that arises from or relates to either Party's failure to comply with any federal, national, state, provincial, international, or local law, statute, regulation or ordinance applicable to such Party's performance hereunder. 10.5 Notices",
    ". 10.5 Notices. All notices, requests, demands, waivers, instructions, consents and other communications to be given pursuant to the terms of this Agreement will be in writing and will be deemed to have been duly given upon receipt if delivered by hand, sent by a nationally recognized overnight mail service, or mailed by registered or certified mail, return receipt requested, postage prepaid: If to Stryker, addressed to: Howmedica Osteonics Corp. c/o Stryker Corporation Attn: Legal Department, [**] 325 Corporate Drive Mahwah, NJ 07430 If to Conformis, addressed to: Conformis, Inc. Attn: Chief Executive Officer and General Counsel 600 Technology Park Drive Billerica, MA 01821 With a copy (which shall not constitute notice) to: 27 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "with respect to any such Third Party or Affiliate, the other Party shall have the right to seek relief in any court of competent jurisdiction in connection with any dispute involving such Third Party or Affiliate. 10.9 Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof",
    ". The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any term or other provision of this Agreement, or the application thereof to any Person or any circumstance, is invalid, illegal or unenforceable by a Court of competent jurisdiction, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity, illegality or unenforceability, nor shall such invalidity, illegality or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. 10.10 Entire Agreement and Third-Party Beneficiaries",
    ". 10.10 Entire Agreement and Third-Party Beneficiaries. This Agreement (including the Other Agreements) contains the entire agreement by and among the Parties with respect to the subject matter hereof and there are no agreements, understandings, representations or warranties between the Parties other than those set forth or referred to herein. This Agreement is not intended to confer upon any Person not a party (or their successors and assigns permitted by Section 10.2), and to the extent expressly provided, their Affiliates, Agents, employees and representatives, any rights or remedies hereunder, except that Section 7.3(a) and Section 7.3(b) hereof are intended to benefit, and to be enforceable by, any of the Relevant Indemnified Parties therein described. 10.11 Jointly Prepared. This Agreement has been prepared jointly and shall not be strictly construed against any Party. 29 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "10.12 Expenses. Except as otherwise set forth in this Agreement and the Other Agreements, all legal and other costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby will be paid by the Party incurring such costs and expenses. 10.13 Counterparts and Electronic Transmission. This Agreement may be executed in one or more counterparts, all of which will be considered one and the same agreement, and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Party. This Agreement may be executed and delivered by facsimile or e- mail transmission with the same effect as if a manually signed original was personally delivered. 10.14 Negotiation in Event of Dispute",
    ". 10.14 Negotiation in Event of Dispute. In the event of any dispute or disagreement between any of the Parties as to the interpretation of any provision of this Agreement or any agreement incorporated herein, the performance of obligations hereunder or thereunder, or any other disputed matter relating hereto or thereto, such matter, upon the written request of any Party, will be referred to an executive of each Party. Such executives will promptly meet in good faith to resolve the dispute. If the executives do not agree upon a decision within thirty calendar days after the reference of the matter to them, any Party will be free to exercise any remedies available to it. 10.15 Rules of Construction",
    ". 10.15 Rules of Construction. As used in this Agreement, the words \"include\", \"includes\" and \"including\" means \"including without limitation\", and no inferences or conclusions of any sort shall be drawn from the fact that in some instances in this Agreement the words \"include\", \"includes\" and \"including\" are actually followed by the phrase \"without limitation\" or the equivalent while in other instances they are not. Except where the context expressly requires otherwise, the use of any gender herein will be deemed to encompass references to any gender, and the use of the singular will be deemed to include the plural (and vice versa). 30 Source: CONFORMIS INC, 10-Q, 11/1/2019",
    "[Signature Page Follows] 31 Source: CONFORMIS INC, 10-Q, 11/1/2019\nIN WITNESS WHEREOF, the parties have caused this Development Agreement to be duly executed as of the respective dates written below. HOWMEDICA OSTEONICS CORP. CONFORMIS, INC. By: /s/ Spencer Stiles By: /s/ Mark A. Augusti Name: Spencer Stiles Name: Mark A. Augusti Title: President Title: President and CEO Date: September 26, 2019 Date: 9-30-2019 [Signature Page to Development Agreement] Source: CONFORMIS INC, 10-Q, 11/1/2019\nExecution Version Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. Source: CONFORMIS INC, 10-Q, 11/1/2019"
  ]
}